| Microemulsion-based media in nose-to-brain drug delivery A Froelich, T Osmałek, B Jadach, V Puri, B Michniak-Kohn Pharmaceutics 13 (2), 201, 2021 | 63 | 2021 |
| Recent advances in polymer-based vaginal drug delivery systems T Osmałek, A Froelich, B Jadach, A Tatarek, P Gadziński, A Falana, ... Pharmaceutics 13 (6), 884, 2021 | 60* | 2021 |
| Evaluations of quality by design (QbD) elements impact for developing niosomes as a promising topical drug delivery platform P Shah, B Goodyear, A Haq, V Puri, B Michniak-Kohn Pharmaceutics 12 (3), 246, 2020 | 46 | 2020 |
| In vitro release, ex vivo penetration, and in vivo dermatokinetics of ketoconazole-loaded solid lipid nanoparticles for topical delivery M Ramzan, S Gourion-Arsiquaud, A Hussain, JS Gulati, Q Zhang, ... Drug Delivery and Translational Research, 1-25, 2022 | 19 | 2022 |
| Effect of penetration enhancers on transdermal delivery of oxcarbazepine, an antiepileptic drug using microemulsions A Virani, V Puri, H Mohd, B Michniak-Kohn Pharmaceutics 15 (1), 183, 2023 | 18 | 2023 |
| Iontophoresis to Overcome the Challenge of Nail Permeation: Considerations and Optimizations for Successful Ungual Drug Delivery K Chen, V Puri, B Michniak-Kohn The AAPS Journal 23 (1), 2021 | 17 | 2021 |
| Nanostructured non-ionic surfactant carrier-based gel for topical delivery of desoximetasone P Shah, B Goodyear, N Dholaria, V Puri, B Michniak-Kohn International journal of molecular sciences 22 (4), 1535, 2021 | 14 | 2021 |
| Quality by design guided development of polymeric nanospheres of terbinafine hydrochloride for topical treatment of onychomycosis using a nano-gel formulation V Puri, A Froelich, P Shah, S Pringle, K Chen, B Michniak-Kohn Pharmaceutics 14 (10), 2170, 2022 | 13 | 2022 |
| Antifungal nail lacquer for enhanced transungual delivery of econazole nitrate V Puri, R Savla, K Chen, K Robinson, A Virani, B Michniak-Kohn Pharmaceutics 14 (10), 2204, 2022 | 9 | 2022 |
| Quality by design: A systematic approach using an advanced statistical tool to optimization of niosomes preparation for the topical delivery P Shah, B Goodyear, A Haq, V Puri, B Michniak-Kohn therapy 6 (7), 2020 | 2 | 2020 |
| An overview of bioequivalence requirements for generic transdermal products D Ameen, N Dholaria, A Haq, B Goodyear, H Mohd, P Shah, A Virani, ... Time-Proof Perspectives on Bioequivalence, 197-220, 2023 | 1 | 2023 |
| Natural Products and Stem Cells and Their Commercial Aspects in Cosmetics S Trehan, R Soskind, J Moraes, V Puri, B Michniak-Kohn Cosmetic Formulation, 221-250, 2019 | 1 | 2019 |
| Design & Development of Topical Formulations for Ungual Drug Delivery of Antifungal Moieties V Puri Rutgers The State University of New Jersey, School of Graduate Studies, 2021 | | 2021 |
Parinbhai ShahCosette Pharmaceuticals., Rutgers UniversityVerified email at scarletmail.rutgers.edu
